isosorbide dinitrate has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bizzozero, L; Clementi, E; Falcone, S; Manfredi, AA; Perrotta, C; Prinetti, A; Rovere-Querini, P; Schuchman, EH; Sonnino, S | 1 |
1 other study(ies) available for isosorbide dinitrate and B16 Melanoma
Article | Year |
---|---|
Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dendritic Cells; Drug Synergism; Enzyme Activation; Female; Immunotherapy, Adoptive; Isosorbide Dinitrate; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nitric Oxide Donors; Nitroso Compounds; Sphingomyelin Phosphodiesterase | 2007 |